Item

trans-2-HEXENYL CAPROATE (HEXANOATE) (143)

The material contains 93% minimum of trans-2-HEXENYL CAPROATE (HEXANOATE), with a 7% maximum of cis isomer. There are no impurities greater than 1%. In addition, there is 0.1% synthetic alpha tocopherol added as an antioxidant.
Food Chemical
Attributes
  • Gluten-free
  • Halal
  • Ingredient declaration
  • Kosher
  • PHO-free
  • Ready-to-Eat (RTE)
  • Vegan
  • Non-GMO
Locations
Location name Address
Bedoukian Research, Inc. 6 Commerce Drive Danbury, CT 06810
Documents
Type Location File name Effective Expiration
Ingredient Statement Bedoukian Research, Inc. 143 ingredient.doc 8/16/2024 8/16/2027
Halal Bedoukian Research, Inc. 143halal.pdf 2/28/2025 2/28/2026
Kosher Bedoukian Research, Inc. 143kosh.pdf 3/31/2024 3/31/2025
Product Specification Sheet Bedoukian Research, Inc. 143-spec.pdf 10/6/2020 10/6/2023
Allergens Bedoukian Research, Inc. Allergens.pdf 4/11/2023 4/10/2025
Country of Origin Bedoukian Research, Inc. Country of Origin.pdf 2/9/2024 2/8/2027
HACCP Bedoukian Research, Inc. Flow chart letter.pdf 9/13/2023 9/12/2026
HARPC Food Safety Plan (Item) Bedoukian Research, Inc. FSMA FS Plan Dec 2023 - Confidential.pdf 4/22/2024 4/22/2027
HACCP Process Flow Diagram Bedoukian Research, Inc. HACCP - Simplified Flow Chart 12-2023.pdf 8/16/2024 8/16/2026
Heavy Metal Bedoukian Research, Inc. Heavy Metals current.pdf 8/16/2024 8/16/2026
Item Questionnaire Bedoukian Research, Inc. Item Questionnaire.pdf 1/6/2022 1/5/2025
Nutrition Bedoukian Research, Inc. Nutrition.pdf 4/22/2024 4/22/2027
Pesticide Bedoukian Research, Inc. Pesticide Residue - All products - 2024.pdf 9/23/2024 9/23/2026
California Prop. 65 Bedoukian Research, Inc. Prop 65-143.docx 3/21/2023 3/20/2025
Residual Statement Bedoukian Research, Inc. Residual Solvent Declaration.doc 8/16/2024 8/16/2025
Safety Data Sheet (SDS) Bedoukian Research, Inc. SDS US English - trans-2-HEXENYL CAPROATE (HEXANOATE) # 143.pdf 10/8/2024 10/8/2027
Suitability Requirements Bedoukian Research, Inc. Suitability Requirements.pdf 10/8/2024 10/8/2027
WADA/NSF/NFL Statement Bedoukian Research, Inc. WADA doc.doc 4/21/2025 4/21/2027